Enzalutamide-induced PTH1R-mediated TGFBR2 decrease in osteoblasts contributes to resistance in prostate cancer bone metastases
S. Su, J. Cao, X. Meng, R. Liu, A. Vander Ark, E. Woodford, R. Zhang, I. Stiver, X. Zhang, Z. B. Madaj, M. J. Bowman, Y. Wu, H. E. Xu, B. Chen, H. Yu, X. Li
bioRxiv · Nov 25, 2019 · PreprintCancer Biology